Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
Recruitment status was Active, not recruiting
The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.
Human Immunodeficiency Virus
|Study Design:||Observational Model: Defined Population
Time Perspective: Longitudinal
|Official Title:||Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|
|Study Start Date:||January 2005|
This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites.
People who participated in FRAM 1 may join FRAM 2.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00244803
|United States, Maryland|
|Johns Hopkins University, The Clinical Trials Unit|
|Baltimore, Maryland, United States, 21205|
|Principal Investigator:||Joseph Cofrancesco Jr., M.D.||Johns Hopkins University|